INTRODUCTION
============

The gap junction family of 21 members selectively intermixes and oligomerizes to form connexons, which are frequently referred to as hemichannels ([@B42]). Connexons traffic to the cell surface, where they proceed to dock with connexons from a contacting cell to form an intercellular channel. These channels typically cluster and coalesce into tightly packed structures known as gap junctions ([@B22]). Gap junctional intercellular communication is a fundamental characteristic of almost all contacting cells in the human anatomy, establishing them as critical to human health ([@B22]). Each connexin consists of four α-helical transmembrane domains, two extracellular loops, and a cytoplasmic loop with the amino and carboxyl termini exposed to the cytoplasm ([@B25]). Each major domain of the connexin has been proposed to be important at regulating one or more functional aspects of the channel ([@B14]). In the case of the extracellular loops, they have been shown to be critical at establishing appropriate interconnexon docking domains through the formation of intramolecular disulfide bonds ([@B32]; [@B38]). In connexin-43 (Cx43), the C-terminal domain is involved in binding numerous members of the gap junction proteome, as well as being the substrate for several protein kinases ([@B44]; [@B24]). The cytoplasmic loop of Cx43 has been shown to interact with the C-terminal during pH-dependent channel closure ([@B15]). The present study focuses on the N-terminus of connexins, which has been reported to be important for transjunctional voltage-dependent gating of gap junction channels ([@B14]), regulating ion permeability ([@B14]; [@B33]), and even regulating connexin oligomerization ([@B20]). Crystal structure analysis of Cx26 revealed an α-helical structure within the first 10 amino acids of the molecule, followed by a critical bend at residues 11 and 12 that appeared to act like a hinge in allowing the N-terminus to fold into and plug the narrowest part of the pore in a voltage-dependent gating model ([@B27]). In another study, the first 23 amino acids of the N-terminal of Cx37 were predominantly α -helical between glycine 5 and glutamate 16 ([@B18]). This 11--amino acid domain was dispensable for Cx37 localization to the cell surface but was required for channel and hemichannel function ([@B19]). Not surprisingly, mutations in the N-terminal domain of a number of connexins have been found to be causal of several human diseases, such as neurosensory hearing loss (e.g., Cx26, Cx30, and Cx31; [@B41]), Charcot--Marie--Tooth disease (e.g., Cx32; [@B26]), congenital cataracts (e.g., Cx46 and Cx50; [@B36]), and oculodentodigital dysplasia (ODDD; e.g., Cx43; [@B35]).

Cx43 is by far the most widely found connexin in human anatomy, being found in more than 35 distinct cell and tissue types ([@B22]). Consequently Cx43 has also been the most rigorously studied member of the connexin family. Interest in examining Cx43 structure and function surged when primarily autosomal dominant mutations in the *GJA1* gene were found to be casual of the developmental disorder ODDD ([@B34]). Not surprisingly, this disease manifests as a plethora of symptoms, but the most common affected tissues are localized to the hands, feet, eyes, facial bones, and teeth ([@B34]). Collectively there are \>62 mutations associated with ODDD ([@B23]; [@B35]). The vast majority of these mutations are missense mutations, and 10 of these mutations occur within the N-terminal domain of Cx43 ([@B35]). Approximately 20 ODDD-linked mutants have been examined for their ability to form gap junction channels, and in nearly all cases the missense mutation renders Cx43 either completely or almost completely nonfunctional and also acts to dominantly inhibit the function of wild-type Cx43 ([@B10]; [@B13], [@B12]; [@B8]; [@B28]; [@B30]; [@B31]; [@B35]; [@B4]; [@B46]). However, the vast majority of the mutants examined can traffic to the cell surface, suggesting that they pass the "quality control" mechanism used within the endoplasmic reticulum. We hypothesized that the nature and position of the mutation might inactivate Cx43 by employing different mechanisms and further provide insight into how specific motifs of Cx43 might regulate function.

To that end, we focused on the N-terminal domain, which encodes \>15% of the reported ODDD-linked mutations ([@B35]). We synthesized a polypeptide encoding the first 23 amino acids of native Cx43, an ODDD-linked mutant peptide (G2V), and a mutant-containing peptide (W4A) that has not been reported to be linked to disease and used nuclear magnetic resonance (NMR) spectroscopy to resolve the structures. Through structure and functional analysis of these mutants and others we determined that the nature of the mutation within the N-terminal conveys loss of Cx43 function by distinctly different mechanisms that are rooted in the structure of the N-terminal domain.

RESULTS
=======

Localization and functional status of ODDD-linked, N-terminal--specific Cx43 mutants
------------------------------------------------------------------------------------

There are \>62 Cx43 mutants linked to ODDD, with 10 of these missense mutations mapped to the N-terminal of Cx43 ([@B35]). Analysis of these N-terminal mutants revealed that some mutations would be considered relatively conservative (e.g., D3N or L7V), whereas others either changed the charge or hydrophobicity of the domain (e.g., G2V, Y17S; [Table 1](#T1){ref-type="table"}).

###### 

Peptides that mimic the N-terminal of Cx43.

  -----------------------------------
  Cx43: MGDWSALGKLLDKVQAYSTAGGK
  G2V: M**V**DWSALGKLLDKVQAYSTAGGK
  D3N: MG**N**WSALGKLLDKVQAYSTAGGK
  L7V: MGDWSA**V**GKLLDKVQAYSTAGGK
  L11P: MGDWSALGKL**P**DKVQAYSTAGGK
  Y17S: MGDWSALGKLLDKVQA**S**STAGGK
  S18P: MGDWSALGKLLDKVQAY**P**TAGGK
  W4A: MGD**A**SALGKLLDKVQAYSTAGGK
  G2S: M**S**DWSALGKLLDKVQAYSTAGGK
  -----------------------------------

Peptide amino acid substitutions that mimic Cx43-linked ODDD mutants or non-ODDD mutants are indicated in boldface.

To begin to assess the role of N-terminal mutants, we expressed green fluorescent protein (GFP)--tagged G2V, D3N, L7V, L11P, Y17S, and S18P mutants in Cx43-positive normal rat kidney (NRK) cells to determine whether the mutant would be delivered to the cell surface and assembled into gap junction--like plaques ([Figure 1](#F1){ref-type="fig"}). Similar to wild-type Cx43, the G2V, D3N, and L7V mutants all readily assembled into gap junction--like plaques. Although the L11P, Y17S, and S18P mutants did assemble into plaques, it appeared that the efficiency of this process was low, as large amounts of GFP-tagged mutants were retained within intracellular compartments. To further determine the importance of the N-terminus of Cx43 for gap junction plaque assembly and trafficking to the cell surface, we transfected HeLa ([Figure 2A](#F2){ref-type="fig"}) and NRK ([Figure 2B](#F2){ref-type="fig"}) cells with a construct encoding Cx43^Δ2-7^. Of interest, Cx43^Δ2-7^ was localized to an intracellular compartment consistent with the endoplasmic reticulum, as revealed by immunolabeling for protein disulfide isomerase (PDI; [Figure 2B](#F2){ref-type="fig"}).

![Distribution of N-terminal Cx43 mutants in NRK cells. Cells were transfected with vectors encoding GFP-tagged Cx43 or the G2V, D3N, L7V, L11P, Y17S, or S18P mutant before immunolabeling with anti-Cx43 (red) antibodies. Hoechst 33342 was used to stain the nuclei Arrows indicate gap junction plaque-like structures at sites of cell--cell contact. Bars, 10 μm.](3312fig1){#F1}

![Intracellular distribution of Cx43^Δ2-7^-GFP in HeLa and NRK cells. HeLa (A) or NRK (B) cells were transfected with a vector that encoded a GFP-tagged Cx43 mutant (Cx43^Δ2-7^-GFP) and immunolabeled with anti-Cx43 (red) or anti-PDI (red) antibodies. Hoechst 33342 was used to stain the nuclei. Bars, 10 μm.](3312fig2){#F2}

To assess whether the N-terminal mutants possess the ability to form functional gap junction channels, we expressed full-length Cx43 or the mutants in intercellular gap junctional communication--deficient HeLa cells and assessed whether the cells were capable of passing microinjected Lucifer yellow to contacting cells ([Figure 3A](#F3){ref-type="fig"}). Similar to wild-type cells, all mutant expressing cells could not form Lucifer yellow--permeable gap junction channels. Furthermore, dual whole-cell patch-clamp electrophysiology was used to show that all mutants were incapable of forming functional gap junction channels when expressed in gap junction communication--incompetent neuroblastoma (Neuro-2A \[N2A\]) cells ([Figure 3C](#F3){ref-type="fig"}). We also examined whether the mutants would dominantly inhibit the gap junction channel function of coexpressed endogenous Cx43 by blocking Lucifer yellow dye transfer ([Figure 3B](#F3){ref-type="fig"}). Again in all cases, the mutants significantly decreased the incidence of dye transfer, suggesting that they were dominant to the function of endogenous Cx43.

![N-terminal--linked Cx43 mutants do not make functional intercellular channels and exhibit dominant-negative properties on coexpressed endogenous Cx43. HeLa (A) or NRK (B) cells expressing Cx43 or mutants were pressure microinjected with 5% Lucifer yellow, and the incidence of dye transfer to neighboring cells was assessed (*n* \> 20 for each group). (C) N2A cells expressing wild-type or Cx43 mutants were patch-clamped to measure electrical coupling conductance. In all cases, the mutants failed to form functional gap junction channels (A, C) and exhibited dominant-negative properties on coexpressed Cx43 (B). WT, untransfected wild-type cells; control in C, untransfected N2A cells.](3312fig3){#F3}

Structural analysis of N-terminal peptides mimicking wild-type and mutant Cx43
------------------------------------------------------------------------------

Because all the Cx43 mutants found throughout the N-terminal domain assembled into gap junction--like structures but failed to form functional channels, we reasoned that the mechanism behind the loss of function might be unique to the position of the mutation and the nature of the amino acid substitution. To begin to address this question, we first determined the structure of a 23-mer N-terminal peptide from wild-type Cx43 ([Figure 4](#F4){ref-type="fig"}). In aqueous solution at neutral pH, NMR spectra of the N-terminal peptide from Cx43 displayed little regular secondary structure (unpublished data) but did show some chemical shifts that were consistent with α-helical character. Previous studies with a Cx26 N-terminal peptide showed that α-helical structure can be observed under similar conditions that can be stabilized using 30% trifluoroethanol (TFE) as a cosolvent ([@B1]). These observations are consistent with other studies, in which 30% TFE appears to be optimal for helix stability of N-terminal peptides from Cx32, Cx36, and Cx43 ([@B11]). The NMR assignment and three-dimensional structure of the wild-type Cx43 N-terminal peptide was determined in a mixture of water and a minimal amount of TFE (30%). The 10 lowest-energy structures were determined ([Figure 4](#F4){ref-type="fig"}) using \>600 distance restraints. The structures showed no distance violations of \>0.5 Å and had acceptable bond and angle deviations from ideal geometry, with satisfactory Ramachandran statistics ([Table 2](#T2){ref-type="table"}). In all structures the wild-type Cx43 peptide displayed a short α-helix between residues W4 and L7, a turn centered at residues G8 and K9, and a longer α-helix between residues L10 and A20. The overall fold was very similar to that displayed by an N-terminal peptide of Cx32, which also folds back on itself ([@B17]). In Cx43, the turn was a result of interactions between W4 near the N-terminus of the peptide and L7 and L11 in the longer α-helix that was supported by numerous cross-peaks in nuclear Overhauser effect spectroscopy (NOESY) spectra (i.e., pairs of protons residing within 6 Å apart in the folded peptide) between the indole ring of W4 with the side chains from L7 and L11. The tryptophan indole ring (W4) in Cx43 packs against the side chains of both leucine residues, burying ∼100 Å of hydrophobic surface area. Similar interactions were observed between W3 and L6, L9, and L10 in the three-dimensional structure of the N-terminal peptide from Cx32 ([@B17]).

![Ribbon representations of Cx43 N-terminal and mutant peptide structures as revealed by NMR analysis. The superpositions of the 10 best structures for the native 23--amino acid Cx43 N-terminal peptide (WT) and peptides containing single--amino acid substitutions (W4A, G2V) are shown (left), along with a ribbon structure of the most representative structure (right). In each case, the side chains of key residues (described in the text) are shown along with the one-letter amino acid name and sequence number. All peptides are shown in a similar orientation based on the superposition of residues D12--Y17.](3312fig4){#F4}

###### 

Structural statistics for N-terminal Cx43 peptides.

                                                   WT                      G2V                     W4A
  ------------------------------------------------ ----------------------- ----------------------- -----------------------
  **rmsd from experimental distance restraints**                                                   
  Unambiguous NOEs (Å)                             0.0271 ± 0.0015 (570)   0.0249 ± 0.0044 (678)   0.0234 ± 0.0043 (544)
  Number of violations \> 0.5 Å                    0                       0                       0
  Ambiguous NOEs (Å)                               0.0259 ± 0.0024 (127)   0.0413 ± 0.0062 (101)   0.033 ± 0.004 (106)
  Number of violations \> 0.5 Å                    0                       0                       0
  **Deviations from ideal geometry**                                                               
  Bonds (Å)                                        0.0051 ± 0.0002         0.0051 ± 0.0003         0.0042 ± 0.0005
  Angles (deg)                                     0.603 ± 0.011           0.611 ± 0.037           0.498 ± 0.033
  Impropers (deg)                                  1.75 ± 0.08             1.35 ± 0.17             1.19 ± 0.12
  **Ramachandran statistics**                                                                      
  Most-favored regions (%)                         76.8                    78.2                    93.6
  Additional allowed regions (%)                   17.4                    21.1                    6.4
  Generously allowed regions (%)                   5.9                     0.6                     0.0
  Disallowed regions (%)                           0.0                     0.0                     0.0
  **rmsd from mean structure^a^**                                                                  
  Backbone atoms (Å)                               0.20 ± 0.04             0.31 ± 0.05             0.38 ± 0.18
  Heavy atoms (Å)                                  0.52 ± 0.05             0.56 ± 0.04             0.67 ± 0.21

Statistics are listed for the 10 lowest-energy conformers of the wild-type (WT), G2V, and W4A substituted peptides. Number of experimental restraints is given in parentheses.

^a^rmsd is shown for the ordered portions of the structures as determined using protein structure validation software; WT (A3--A20), G2V(A3--A20), and W4A(S5-T19).

The bent-helical structure of the N-terminus of Cx43 (and Cx32) differs from the regular α-helix found for the N-terminus of Cx26 observed from its three-dimensional structure ([@B27]). In the isolated peptide, W4 in Cx43 likely packs against L7 and L11 to minimize hydrophobic surface exposure in the absence of the remainder of the protein. This arrangement contrasts that of Cx26, in which W3 interacts with I33, M34, and V37 of transmembrane helix 1 (TM1) of an adjacent protomer in the hexamer. In the context of the intact Cx43 protein, W4 would probably be recruited by the analogous TM1 residues (I34, L35) and take on a similar regular α-helical structure as observed in Cx26 ([@B27]). To test this idea, we substituted W4 with an alanine with the rationale that substitution to a smaller side-chain residue would relieve the interactions with L7 and L10, allowing the structure to assume a more elongated α-helix similar to that observed in Cx26. Using similar conditions as for the wild-type peptide, we determined the solution structure of the W4A Cx43 peptide by NMR spectroscopy ([Figure 4](#F4){ref-type="fig"}). The W4A polypeptide formed a contiguous α-helix from residues S5 to T19, with excellent similarity among the 10 structures (root-mean-square deviation \[rmsd\], 0.38 Å). These findings indicated that the W4A substitution formed a regular, nonkinked α-helix. We believe that this structure will be more representative of the native N-terminus in Cx43.

The solution structure of an N-terminal peptide from Cx43 containing the G2V variant linked to ODDD was also determined. As with the wild-type and W4A peptides, the G2V peptide displayed excellent structural characteristics (rmsd, 0.31 ± 0.05 Å). Although the G2V peptide had a comparable helical structure to both wild-type and W4A peptides toward its C-terminus (D12--Y17; rmsd, 0.37 ± 0.19 Å), it showed a bent helix near its N-terminus similar to that shown by the wild-type structures. As described for the wild-type peptide, this is a result of W4 interactions with L7 and L11. However in G2V, further important hydrophobic interactions exist involving V2 that are not present in the wild-type peptide. Specifically, the glycine-substituted valine interacts with W4 by positioning its CH~3~ groups against the back side of the tryptophan indole, opposite from L7 and L11 ([Figure 4](#F4){ref-type="fig"}). This has the effect of sandwiching the W4 indole ring between a series of hydrophobic residues. We propose that these additional interactions in the G2V mutant would inhibit the interactions of W4 with residues in TM1 and compromise gap junction function.

Predictive structure and function studies
-----------------------------------------

On the basis of the structures of the wild-type, W4A, and G2V Cx43 peptides, we designed experiments to test the Cx43 distribution and function of these and additional mutants. To assess how the W4A substitution would affect the distribution and function of Cx43, we engineered the Cx43 cDNA to encode this mutation and expressed the mutant in both gap junctional communication--deficient HeLa cells and Cx43-positive NRK cells. Of interest, the W4A mutant was found to form gap junction--like plaques ([Figure 5A](#F5){ref-type="fig"}). However, like the G2V and all other N-terminal missense mutants, the W4A mutant did not form functional gap junctions and acted as a dominant negative on coexpressed Cx43 ([Figure 6, A and B](#F6){ref-type="fig"}).

![Localization of the W4A and G2S Cx43 mutants in NRK cells. NRK cells were transfected with vectors encoding W4A-GFP (A) or G2S-GFP (B) and immunolabeled with anti-Cx43 antibodies (red) before Hoechst 33342 staining (blue). Arrows indicate that the mutants were localized to gap junction--like structures at cell--cell interfaces. Bars, 10 μm.](3312fig5){#F5}

![The G2S, but not the G2V or W4A, mutant forms functional gap junctions. (A) NRK and HeLa cells were untreated (WT) or engineered to express W4A-GFP or G2S-GFP before microinjection with 5% Lucifer yellow and assessment of dye transfer. (B) Gap junctional intercellular communication--deficient N2A cells were engineered to express Cx43-GFP, W4A-GFP, G2V-GFP, or G2S-GFP. Patch-clamp analysis was used to assess gap junction coupling conductance. Whereas the W4A and G2V mutants did not form functional gap junction channels, the G2S mutant exhibited functional conductance that even exceeded that of Cx43. The numbers above each column depict the number of cell pairs recorded.](3312fig6){#F6}

Because the structure of the G2V peptide showed interactions with W4 that impede function, it was rationalized that a more conservative amino acid substitution at G2 could relieve this interaction and lead to the retention of Cx43 channel function or even result in gain of channel function. Thus we engineered a construct to encode a G2S substitution and expressed this Cx43 variant in HeLa and NRK cells. As predicted from the structural analysis, this mutant assembled into gap junction plaque structures ([Figure 5B](#F5){ref-type="fig"}). Of importance, dye microinjection studies revealed that the G2S mutant was functional and failed to act as a dominant negative on coexpressed endogenous Cx43 ([Figure 6A](#F6){ref-type="fig"}). To further validate that the G2S mutant formed functional gap junction channels, we performed dual whole-cell patch-clamp analysis on N2A cells engineered to express wild-type Cx43 or mutants. We found that cells expressing either the W4A or G2V mutant exhibited no significant coupling, whereas cells expressing the G2S mutant exhibited robust electrical coupling that exceeded that of wild-type Cx43, suggesting that the G2S mutant might in fact favor a more open channel state or that more channels are assembled ([Figure 6B](#F6){ref-type="fig"}).

DISCUSSION
==========

ODDD and N-terminal domain--specific Cx43 mutants
-------------------------------------------------

There is a plethora of Cx43 mutations that cause ODDD, with 15% of the mutations resulting in single--amino acid substitutions in the first 23 amino acids of Cx43 ([@B35]). These patients, in addition to having the classic ocular, dental, and digital developmental defects, also exhibited some uncommon features, such as cleft palate (25% of all N-terminal patients), hair problems (75%), hearing loss (50%), and/or neurological symptoms and urinary track defects (25%; [@B35]). For example, a patient harboring the G2V mutant was reported to have bilateral optociliary veins and umbilical hernia, which were also reported in a S18P mutant--harboring patient ([@B6]). In another study a D3N ODDD patient was reported to have a tethered tongue, heart murmur, kidney malfunction, and neurological symptoms ([@B5]). Thus it would seem that each ODDD patient who carries an N-terminal--specific mutation can exhibit symptoms that go beyond the common developmental disorders associated with ODDD, raising the question as to whether N-terminal--specific mutations might have variable mechanisms for inactivating Cx43 channels. Because the highly conserved N-terminal domain of connexins has been proposed to play multiple functional roles, ranging from initiating protein insertion and oligomerization to physically plugging the functional pore ([@B14]; [@B20]; [@B33]), it seemed plausible that a specific amino acid substitution might alter channel function by very different mechanisms. In the present study we combine NMR studies with mutant expression and functional studies to determine how the structural organization of the N-terminal dictates functional outcome, which might help to further explain the diversity of clinical symptoms manifested in ODDD patients.

Trafficking, localization, and function of N-terminal--specific mutants
-----------------------------------------------------------------------

In the present study all six naturally occurring ODDD-linked, N-terminal--specific mutants were capable of trafficking to cell surface and forming gap junction plaque-like structures, not unlike what was reported for the G21R and Y17S mutants ([@B40]; [@B21]; [@B12]). Of interest, the efficiency of plaque formation appeared to decrease when the amino acid substitution occurred more distal to the extreme amino terminus, as more of the L11P, Y17S, and S18P mutants were retained in intracellular compartments. Nevertheless, all point mutants were capable of membrane insertion and delivery to the cell surface, even in the absence of coexpressed wild-type Cx43. These findings raised the question as to how important the amino terminal is in general for Cx43 insertion, transport, and assembly into a plaque-like structure at the plasma membrane. To address this question, we expressed a Cx43^Δ2-7^ mutant and found that the loss of six amino acids from the N-terminal completely inhibited the ability of the mutant to exit the endoplasmic reticulum and localize to the plasma membrane. This was somewhat surprising, as recently it was reported that the substitution of amino acids 2--8 to alanines did not impair the ability of Cx37 to form plaque-like structures, and a deletion of nine amino acids or more was necessary to cause Cx37 to remain within an intracellular compartment ([@B19]). Our studies suggest that smaller deletions of Cx43 N-terminal motifs are more potent at inhibiting the transport and assembly of Cx43, and both studies suggest that the N-terminal is critical for connexin assembly.

It is interesting that all six ODDD-linked, N-terminal mutants failed to form functional gap junctions, suggesting that the N-terminal domain is critical for proper channel assembly and function, as previously demonstrated for the G21R and D3N mutants ([@B29]; [@B40]; [@B12]; [@B5]). Of importance, these same mutants exhibited dominant-negative properties on coexpressed endogenous Cx43, suggesting that patients who harbor these mutants are likely surviving on far less than 50% of normal Cx43 function. Mechanistically it is likely that the mutants are co-oligomerizing with endogenous Cx43 and are able to transport to the cell surface and form plaque-like structures but that the resulting channel pores are incapable of passing small molecules. These studies raised the question as to how each mutant changes the structure of the N-terminus and whether the mutants cause similar or different structural changes.

N-terminal Cx43 mutations differentially alter structure
--------------------------------------------------------

The structure of membrane protein motifs is always difficult to predict due to their anchoring in hydrophobic membrane bilayers. However, several lines of evidence suggest that NMR analysis of untethered polypeptide domains can prove useful in establishing structural information on connexin domains that are exposed to the cytoplasm, including intramolecular distances and α-helical formations ([@B9]; [@B48], [@B47]; [@B3]). Cx43 belongs to the α-subfamily of connexins and contains 23 amino acids before the start of the first transmembrane domain according to most topological models ([@B43]). Polypeptides of the first 23 amino acids of native Cx43, amino acid substitutions that mimic ODDD mutants, and amino acid substitutions that do not mimic ODDD mutants were synthesized, and NMR spectra were obtained and analyzed. Wild-type Cx43 N-terminal peptide exhibited an amphipathic character, with an α-helix running between L10-A20 similar to that observed in the structure of an N-terminal peptide from Cx32 ([@B17]) and the crystal structure of Cx26 ([@B27]). Surprisingly, a single turn centered at residues G8 and K9 resulted in the formation of a small hydrophobic cluster comprising W4, L7, and L11. A similar kinked-helix structure was observed for an N-terminal peptide from Cx32 ([@B17]). Within the hexameric structure of Cx43 it is unlikely that W4 retains this relationship with the remainder of the N-terminus. Instead, the N-terminus of Cx43 likely adopts an "unkinked" structure, elongating the helix and taking on interactions with residues in TM1 similar to those observed in Cx26. In line with this, substitution of W4 to a smaller side chain residue (alanine) relieved interactions with L7 and L11 and resulted in a rigid, contiguous α-helix that "unkinked" the N-terminus. This structure for the N-terminus would fit well with respect to the remaining transmembrane helices. In contrast, the G2V substitution resulted in a larger hydrophobic cluster, where W4 was now sandwiched between V2, L7, and L11. It is possible that the glycine-to-valine substitution might prevent W4 from interacting with I34 and L35 in TM1 of the adjacent Cx43 protein in the hexamer and compromise transjunctional exchange of molecules. The observation that a G2S substitution maintains Cx43 function supports this idea, suggesting that the glycine can be substituted without destroying Cx43 function.

Predicted structure determination of gap junction channels
----------------------------------------------------------

Connexins are considered to share a common architecture for gap junction channel formation ([@B43]). For example, the N-terminal is 45% conserved between Cx43 and Cx26. According to the published Cx26 structure and homology comparisons with human Cx43 ([@B27]), any amino acid substitution within the amino termini is predicted to change the structure of the N-terminus and the subsequent interactions between the side chains. As for Cx43, the G2V substitution results in additional hydrophobic interactions with W4. This likely has two consequences. First, the altered structure might disrupt key hydrogen bonds that have been proposed to play an important role in forming a circular hydrogen bond network to stabilize the pore funnel observed in Cx26. In the Cx26 protein structure, D2 in each protomer forms a hydrogen bond with T5 of the neighboring protomer that stabilize the funnel structure. In Cx43, the interaction of V2 in the G2V mutant might prevent W4 from interactions with residues in TM1, which might ultimately regulate channel opening. In support of this interpretation, both dye coupling and electrical conductance analysis revealed that the G2V mutants formed nonfunctional gap junction channels and exhibited dominant-negative properties on coexpressed Cx43.

On the basis of on our NMR studies, we found that W4A peptide forms a contiguous α-helix from residues S5 to T19 with excellent similarity among the 10 structures analyzed (rmsd, 0.38 Å). Although this structure aligns well with that for Cx26, the W4A mutant lost the ability to form functional channels. In Cx26, W3 makes important contacts with I33, M34, and V37 in TM1 of an adjacent protomer that is believed to maintain the channel in an "open" conformation. Substitution of M34 causes channel defects in Cx26. It would be expected that W4 in Cx43 has similar contacts with TM1 (I34, L35), and its substitution to alanine disrupts similar contacts, presumable closing the channel. Not surprisingly, the W4A mutant was indeed found to be nonfunctional. To further assess the possible recovery of the channel structure, we found that G2S mutant not only was able to form functional channels but also uniquely exhibited gain-of-macroscopic coupling levels exceeding those of wild-type Cx43. Given that serine (CH~2~OH) has a small side chain similar to glycine as found in many other α connexins, this might be important in regulating the open state of the channel. Thus it appears that maintaining a small amino acid residue in the second amino acid position of Cx43 is essential for channel function.

In summary, we found that all ODDD-linked, N-terminal Cx43 mutants can traffic to the cell surface and assemble into nonfunctional gap junction--like structures. Furthermore, all ODDD-linked mutants exhibit dominant-negative properties on coexpressed Cx43, suggesting that ODDD patients are functioning on far less than 50% of normal Cx43 gap junction channel function. NMR structure analysis showed the importance of positions G2 and W4 in channel formation, regulation, and function. Our results further suggest that an elongated α-helical structure at the N-terminus of Cx43 is likely essential for Cx43 channel formation and function. Furthermore, the integrity of the N-terminus is necessary for Cx43 trafficking to cell surface, and conserved strategic amino acid substitutions can occur in the N-terminus that can even enhance channel function. Finally, the nature of the ODDD-linked mutations within the N-terminal conveys loss of Cx43 function by distinctly different mechanisms that are rooted in the structure of the N-terminal domain.

MATERIALS AND METHODS
=====================

Cells and reagents
------------------

NRK, mouse N2A, and human cervical tumor (HeLa) cells obtained from the American Type Culture Collection (Manassas, VA) were grown in high-glucose (4500 mg glucose/l) DMEM (Invitrogen, Burlington, Canada) supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, and 2 mM [l]{.smallcaps}-glutamine (except N2A cells). Cells were cultured within a humidified environment that maintained 5% CO~2~ and a temperature of 37°C.

Mutant DNA constructs
---------------------

Human Cx43 mutants (G2V, D3N, L7V, L11P, Y17S, S18P, W4A, and G2S) untagged and/or GFP tagged were constructed or special purchased from Norclone Biotech Industries (London, Canada). Briefly, mutations were generated that changed the code of the amino acid Gly (G) to Val (V) or Ser (S) at the 2nd position, Asp (D) to Asn (N) at the 3rd position, Leu (L) to Val (V) at the 7th position, Leu (L) to Pro (P) at the 11th position, Try (Y) to Ser (S) at 17th position, Ser (S) to Pro (P) at the 18th position, and Trp (W) to Ala (A) at the 4th position. All cDNA constructs were cloned into the pEGFP-N1 vector (BD Biosciences, Clontech, La Jolla, CA), resulting in all mutants being tagged with GFP. The cDNA construct encoding wild-type Cx43-GFP was previously engineered. The fidelity of the constructs was confirmed by DNA sequencing at the Robarts Research Institute DNA Sequencing Facility (London, Canada) using an Applied Biosystems (Foster City, CA) 3730 analyzer.

Engineering of GFP-tagged Cx43^Δ2-7^ construct
----------------------------------------------

To engineer GFP-tagged Cx43^Δ2-7^ (where residues 2--7 were deleted from the N-terminal), we designed a forward primer by using 5′-TCC AAT GGT ACC ATG [GGC AAA CTC CTT-3′]{.ul}, which added a *Kpn*I restriction enzyme site, and a reverse primer 5′-CGC GGA TCC TT[G ATC TCC AGG TCA TCA G]{.ul}-3′, which added a *Bam*HI restriction enzyme site. PCR products were cloned into the pEGFP-N1 vector. DNA sequencing confirmed the deletion of the amino acids 2--7 from the N-terminal of human Cx43, with the addition of a seven--amino acid linker connecting, in-frame, the Cx43 mutant to GFP.

Transfections and immunofluorescent labeling
--------------------------------------------

For transient transfections, NRK, HeLa, and N2A cells were grown to ∼70% confluency in 60-mm culture dishes containing glass coverslips. To prepare the transfection mixtures, we used 250 μl of OptiMEM-I medium (Life Technologies, Burlington, Canada). Between 2 and 5 μg of cDNA was added to one tube, and 3 μl of Lipofectamine 2000 (Invitrogen) was added to a second tube. The tubes were combined within 5 min, gently mixed, and allowed to sit at room temperature for 15 min. The transfection mixtures were then added to the cells. After 4 h, the transfection mixture was removed and replaced with regular media for 48 h.

For immunolabeling studies, a mixture of 80% methanol/20% acetone was added to cultured cells for 20 min at 4°C and then replaced with phosphate-buffered saline (PBS). Cells were treated with 2% bovine serum albumin in PBS for 30 min to block nonspecific binding sites. A rabbit anti-Cx43 polyclonal antibody (1:500 dilution; Sigma-Aldrich, Oakville, Canada) and an anti-PDI (1:500 dilution; Stressgen, Enzo Life Sciences, San Diego, CA) antibody (an endoplasmic reticulum marker) were used. Coverslips were exposed to primary antibodies and fluorescent-tagged secondary antibodies (rabbit Alexa 555 \[Invitrogen\]) for 1 h at room temperature. Cell nuclei were stained for 5 min with Hoechst 33342 (10 μg/ml) and then rinsed in doubly distilled (dd) H~2~O before mounting.

Dye transfer
------------

Cells expressing Cx43 or Cx43 mutants were randomly pressure injected with 5% Lucifer yellow dye dissolved in ddH~2~O (Molecular Probes, Eugene, OR) using an Eppendorf Femtojet automated pressure microinjector until the cell brightly fluoresced. Images were collected 1--3 min after injection using OpenLab software (Quorum Technologies, Guelph, Canada). The instances of dye transfer were quantified.

Patch-clamp electrophysiology
-----------------------------

Functional gap junction coupling between paired N2A cells expressing fluorescent protein--tagged mutant and/or wild-type Cx43 was assessed using the dual whole-cell patch-clamp technique as previously described ([@B13], [@B12]). Isolated cell pairs with green fluorescent plaques (representing GFP-tagged Cx43 or mutant Cx43) at cell--cell contacts were chosen for patch-clamp recording. The cells were constantly perfused in an external solution containing 140 mM NaCl, 5 mM KCl, 2 mM CsCl~2~, 2 mM CaCl~2~, 1 mM MgCl~2~, 5 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 5 mM [d]{.smallcaps}-glucose, 2 mM pyruvate, and 1 mM BaCl~2~, pH 7.4. Junctional current was measured between cell pairs by using the dual whole-cell voltage-clamp technique with Axopatch 200B patch-clamp amplifiers (Axon Instruments, Union City, CA) at room temperature (22--25°C). Recording patch pipettes were prepared with a puller (PP-83; Narishige Scientific Instrument, Tokyo, Japan). The patch pipette had a resistance of 2.5--5.5 MΩ when filled with an internal solution containing 130 mM CsCl~2~, 10 mM ethylene glycol tetraacetic acid, 0.5 mM CaCl~2~, 3 mM MgATP, 2 mM Na~2~ATP, and 10 mM HEPES, pH titrated to 7.2 with CsOH. Data were low-pass filtered at 2 kHz and were acquired using pClamp9 software (Axon Instruments) and digitized at a 5- to 10-kHz sampling rate. Each cell of a pair was initially held at a common holding potential of 0 mV. To evaluate junctional coupling, we applied 7-s hyperpolarizing pulses from the holding potential of 0 to −20 mV to one cell to establish a transjunctional voltage gradient, and we measured the junctional current in the second cell. Macroscopic junctional conductance (*g*~j~) was calculated from *g*~j~ = *I*~j~/*V*~j~, where *I*~j~ is the measured junctional current and *V*~j~ is transjunctional voltage. The experimenter was blind to the connexin subtypes when performing the patch-clamp experiments. Student\'s *t* test was performed with Excel (Microsoft, Redmond, WA).

Peptide synthesis and sample preparation
----------------------------------------

Peptides corresponding to the N-terminal first 23 residues (MGDWSALGKLLDKVQAYSTAGGK) or Cx43 peptides with the G2V or W4A amino acid substitutions were high-performance liquid chromatography purified, and purity was confirmed by electron ionization spectrometry (Genemed Synthesis, San Antonio, TX). NMR-ready samples were prepared by dissolving each peptide (∼1 mM) in buffer containing 50 mM sodium phosphate, pH 5.2, 100 mM NaCl, and 30% H~2~O/10% 2.2.2-trifluoroethanol-D3 D~2~O/30% TFE-d~3~ (vol/vol; Cambridge Isotope Laboratories, Andover, MA).

NMR spectroscopy
----------------

All experiments were acquired on an Inova 600-MHz spectrometer (Varian, Palo Alto, CA) equipped with a ^13^C-enhanced triple-resonance cold probe at 12ºC. Two-dimensional homonuclear ^1^H--^1^H total correlation spectroscopy (TOCSY; mixing time τ~m~ = 80 ms; [@B2]) and ^1^H--^1^H NOESY (τ~m~ = 200 ms; [@B45]) spectra were collected using spectral widths of 7000 Hz in both dimensions with 1104 and 552 complex points in t2 and t1 dimensions, respectively. Water suppression was achieved with the WATERGATE pulse sequence ([@B37]). All spectra were processed with NMRPipe ([@B7]) and analyzed with NMRView ([@B16]). A 60° shifted sine bell window function was applied to each dimension and then zero filled to 2048 points before Fourier transformation. Sequence-specific ^1^H resonance assignments were obtained using TOCSY and NOESY spectra following standard procedures.

Structure calculations
----------------------

The standard protocol of ARIA2.2 was used for iterated automatic NOE assignment and structure calculations ([@B39]). Distance information was obtained from the volumes of cross-peaks in NOESY spectra and used as input along with chemical shift information for each peptide. Initial manual NOE assignments were used only when unambiguous assignment could be obtained. Each structure calculation was initialized from 20 randomly generated structures followed by eight iterations using the input data. The 10 lowest-energy structures in the final iteration were refined using the water refinement routine in ARIA2.2, submitted to the Protein Structure Validation Suite ([http://psvs-1_4-dev.nesg.org](http://psvs-1_4-dev.nesg.org/)) for structure quality evaluation, and analyzed and displayed using PyMOL ([www.pymol.org](http://www.pymol.org/)).
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